查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1488250

冠狀動脈繞道移植市場- 按方法（傳統（體外循環）、微創直接）、手術類型（單次、兩次、三次、四次）、產品（移植物、牽開器、心臟定位器）、最終用途- 2024 年全球預測- 2032

Coronary Artery Bypass Graft Market - By Method (Traditional (On-pump), Minimally Invasive Direct), Surgery Type (Single, Double, Triple, Quadruple), Product (Grafts, Retractors, Heart Positioner), End-use - Global Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 210 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於領先醫院和協會的認可度不斷提高，2024 年至 2032 年間，全球冠狀動脈搭橋移植物市場規模將達到 6.8% 的複合年成長率。冠狀動脈繞道手術（CABG）是心臟手術的基石，全球範圍內的需求正在不斷成長。領先的醫院正在認知到 CABG 在治療冠狀動脈疾病方面的功效和長期益處。例如，2023 年 6 月，胸腔外科醫師協會 (STS) 授予 Kettering Health Dayton 著名的三星級評級，表彰其在離體冠狀動脈搭橋手術中出色的患者護理和結果。這項傑出的評級使凱特林健康代頓醫院躋身美國和加拿大心臟搭橋手術頂級品質提供者之列。

此外，協會和醫療機構提倡將冠狀動脈繞道手術作為複雜冠狀動脈疾病患者的首選。這種認知正在推動對冠狀動脈繞道手術和相關產品（包括移植物和設備）的需求。因此，CABG 市場正在穩步成長，預計將進一步擴張。這一趨勢凸顯了 CABG 在解決心血管健康問題、確保全球患者擁有更健康未來的重要性。

整個冠狀動脈繞道手術產業根據方法、手術類型、產品、最終用途和地區進行分類。

傳統（體外循環）CABG 領域將在 2024 年至 2032 年間經歷大幅成長。它在恢復心臟血流方面的有效性和長期成功使其成為許多患者和醫生的首選。因此，對 CABG 手術和相關產品的持續需求，推動了 CABG 市場的成長。這項需求強調了傳統 CABG 在心血管醫學中的持續相關性和重要性。

從2024年到2032年，單一CABG手術部分的冠狀動脈繞道手術市場佔有率將出現顯著的複合年成長率。心血管問題的患者提供針對性的治療。與多次搭橋手術相比，該手術可以降低手術風險並加快恢復速度，使其成為越來越受歡迎的選擇。因此，對單次冠狀動脈繞道手術和相關產品的需求顯著，促進了冠狀動脈繞道手術市場的成長。這項需求凸顯了客製化治療方案在有效解決冠狀動脈疾病的重要性。

2024年至2032年，亞太地區的冠狀動脈繞道移植市場將呈現出值得稱讚的複合年成長率。 。醫療保健支出的增加和先進醫療技術的普及進一步推動了對冠狀動脈繞道手術的需求。此外，人們對心血管健康的認知不斷增強以及西化飲食的採用導致對冠狀動脈繞道手術的需求增加。因此，亞太地區的冠狀動脈繞道手術市場顯著成長，反映出該地區越來越重視解決心血管健康問題。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 心血管疾病盛行率增加
      • 科技不斷進步
      • 高血壓盛行率上升
      • 有利的報銷方案
    • 產業陷阱與挑戰
      • 與手術相關的高成本
      • 與手術相關的併發症
  • 成長潛力分析
  • 技術景觀
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章：市場估計與預測：依方法，2018 - 2032

  • 主要趨勢
  • 傳統（體外循環）CABG
  • 微創直接冠狀動脈繞道術
    • 非體外循環冠狀動脈繞道術
    • 鎖孔冠狀動脈繞道手術
    • 其他微創冠狀動脈繞道手術類型

第 6 章：市場估計與預測：按手術類型，2018 - 2032 年

  • 主要趨勢
  • 單次冠狀動脈繞道手術
  • 雙冠狀動脈繞道手術
  • 三重冠狀動脈繞道手術
  • 四次冠狀動脈繞道手術

第 7 章：市場估計與預測：按產品分類，2018 年 - 2032 年

  • 主要趨勢
  • 移植物
    • 大隱靜脈移植物
    • 胸廓內動脈移植物
    • 其他移植物
  • 牽開器
  • 心臟定位器
  • 組織穩定劑
  • 其他產品

第 8 章：市場估計與預測：按最終用途，2018 - 2032 年

  • 主要趨勢
  • 醫院
  • 心臟病中心
  • 其他最終用戶

第 9 章：市場估計與預測：按地區分類，2018 年 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章：公司簡介

  • Edwards Lifesciences Corporation
  • Getinge AB
  • Genesee Biomedical
  • Guidant Corporation
  • LivaNova PLC
  • Medtronic plc
  • Novadaq Technologies Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
簡介目錄
Product Code: 8564

Global Coronary Artery Bypass Graft Market Size will witness 6.8% CAGR between 2024 and 2032 due to increasing recognition from leading hospitals and associations. CABG procedures, a cornerstone of cardiac surgery, are witnessing a rise in demand globally. Leading hospitals are recognizing the efficacy and long-term benefits of CABG in treating coronary artery disease. For instance, in June 2023, The Society of Thoracic Surgeons (STS) awarded Kettering Health Dayton with a prestigious three-star rating for its exceptional patient care and outcomes in isolated coronary artery bypass grafting surgery. This distinguished rating positioned Kettering Health Dayton among the top tier of quality providers in both the United States and Canada for heart bypass surgery.

Moreover, associations and medical bodies are advocating for CABG as a preferred option for patients with complex coronary artery disease. This recognition is driving the demand for CABG procedures and associated products, including grafts and devices. As a result, the CABG market is experiencing steady growth, with projections indicating further expansion. This trend underscores the importance of CABG in addressing cardiovascular health, ensuring a healthier future for patients worldwide.

The overall Coronary Artery Bypass Graft Industry is classified based on the method, surgery type, product, end-use, and region.

The traditional (on-pump) CABG segment will undergo sizeable growth from 2024 to 2032. Despite the emergence of minimally invasive techniques, traditional CABG remains a cornerstone in treating coronary artery disease. Its effectiveness and long-standing success in restoring blood flow to the heart make it a preferred choice for many patients and physicians. As a result, there is a sustained demand for CABG procedures and associated products, driving CABG market growth. This demand underscores the continued relevance and importance of traditional CABG in cardiovascular medicine.

The coronary artery bypass graft market share from the single CABG surgery segment will register a notable CAGR from 2024 to 2032. Single CABG, also known as isolated CABG, involves bypassing a single blocked coronary artery, providing targeted treatment for patients with specific cardiovascular issues. This procedure offers reduced surgical risk and faster recovery than multiple bypass surgeries, making it an increasingly preferred option. As a result, there is a notable demand for single CABG surgeries and associated products, contributing to the growth of the CABG market. This demand highlights the importance of tailored treatment options in addressing coronary artery disease effectively.

Coronary artery bypass graft market from Asia Pacific will showcase a commendable CAGR from 2024 to 2032. Rapid urbanization, changing lifestyles, and an aging population contribute to the increasing prevalence of coronary artery disease in the region. Rising healthcare expenditure and improving access to advanced medical technologies further drive the demand for CABG procedures. Additionally, growing awareness about cardiovascular health and the adoption of Westernized diets lead to a higher demand for CABG surgeries. Consequently, the Asia-Pacific region witnesses significant growth in the CABG market, reflecting the region's increasing focus on addressing cardiovascular health issues.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing in prevalence of cardiovascular diseases
      • 3.2.1.2 Growing technological advancement
      • 3.2.1.3 Rising prevalence of hypertension
      • 3.2.1.4 Favorable reimbursement scenario
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost associated with surgery procedures
      • 3.2.2.2 Complications associated with the surgery
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Method, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Traditional (on-pump) CABG
  • 5.3 Minimally invasive direct CABG
    • 5.3.1 Off-pump CABG
    • 5.3.2 Keyhole CABG
    • 5.3.3 Other minimally invasive CABG surgery types

Chapter 6 Market Estimates and Forecast, By Surgery Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Single CABG surgery
  • 6.3 Double CABG surgery
  • 6.4 Triple CABG surgery
  • 6.5 Quadruple CABG surgery

Chapter 7 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Grafts
    • 7.2.1 Saphenous vein grafts
    • 7.2.2 Internal thoracic artery grafts
    • 7.2.3 Other grafts
  • 7.3 Retractors
  • 7.4 Heart positioners
  • 7.5 Tissue stabilizers
  • 7.6 Other products

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Cardiology centers
  • 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Argentina
    • 9.5.3 Mexico
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Edwards Lifesciences Corporation
  • 10.2 Getinge AB
  • 10.3 Genesee Biomedical
  • 10.4 Guidant Corporation
  • 10.5 LivaNova PLC
  • 10.6 Medtronic plc
  • 10.7 Novadaq Technologies Inc.
  • 10.8 Stryker Corporation
  • 10.9 Teleflex Incorporated
  • 10.10 Terumo Corporation